SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending as the community eagerly discusses the onset of a new year, with many anticipating a significant shift after what some perceive as a challenging period. Conversations frequently highlight expectations for a potential bullish breakout, contrasting with cautionary views from those who believe further downside is possible. The debate centers on whether LTC, often dubbed "digital silver," is poised for substantial growth in the upcoming market cycle.

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions is currently trending after announcing a strategic manufacturing partnership to scale production of its fingerprinting drug screening reader, anticipating significant cost savings and margin improvements ahead of its U.S. market entry. The community is buzzing with speculative interest, comparing it to other low-float runners and actively discussing its potential for substantial further gains amid intense trading volatility.

Sensei Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Rockville, MD.

Sensei Biotherapeutics Inc

Sensei Biotherapeutics (SNSE) is a top trending stock, with intense community discussion centered on its extremely low float and strong potential for a short squeeze. Many traders are actively accumulating shares, comparing it to recent parabolic runners and speculating on a multi-day breakout, especially as the company explores strategic alternatives.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is trending due to the recently completed Ask Sage acquisition, a strategic move many believe enhances its secure generative AI capabilities for defense. However, the repeated postponement of a critical proxy vote is fueling investor uncertainty and spirited debate regarding potential future share dilution. The community remains sharply divided between those anticipating significant government AI contracts and others concerned about immediate operational execution and leadership.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is trending as recent analyst concerns about crypto trading volumes dampen sentiment, fueling a sharp divide among investors. While many express frustration over persistent price declines and perceived underwhelming holiday giveaways, long-term bulls view current dips as an opportunity, citing the platform's expansion into new markets like predictions. The broader conversation frequently links its performance to the cryptocurrency market and year-end market dynamics.

ESH Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 17, 2021 and is headquartered in New York, NY.

ESH Acquisition Corp - Ordinary Shares - Class A

ESH Acquisition Corp ($ESHA) is trending with high volatility, fueled by its low-float SPAC structure and significant insider ownership, which is attracting speculative trading interest. The community is actively discussing its potential for a substantial short squeeze or parabolic run, with many investors encouraging holding shares to capitalize on perceived explosive movements, despite its highly speculative nature.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics (CORT) is trending following a substantial stock drop after the FDA issued a Complete Response Letter for its relacorilant drug, citing the need for more efficacy evidence in Cushing's syndrome. The community is sharply divided, with many investors calling the sell-off an overreaction given the company's strong existing revenue from Korlym and diverse pipeline, prompting some to buy the dip. However, others remain cautious, highlighting the regulatory setback and concerns about potential information leaks to institutions before the public announcement.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending following FDA approval for NEREUS, a significant milestone as the first new motion sickness treatment in over four decades. The community is buzzing with expectations for substantial upside, largely driven by the drug's potential to address GLP-1 associated nausea and positioning VNDA as a prime acquisition target for larger pharma. With additional pipeline catalysts approaching, traders anticipate continued long-term value creation for the company.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is trending following recent regulatory updates, including the FDA's priority review for its AXS-05 Alzheimer's disease agitation treatment and progress towards an NDA submission for AXS-12 in narcolepsy. The community is highly optimistic about these developments and continued strong sales of Auvelity, viewing the company as a future leader in CNS therapeutics with significant pipeline potential. This confluence of catalysts has fueled substantial investor enthusiasm, driving the stock to new highs.

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore Corp. is trending due to the U.S. Department of Transportation's PHMSA approving an emergency special permit to restart critical segments of its Santa Ynez Pipeline System, a move widely seen as bypassing California's state regulatory opposition. This federal backing, viewed by bulls as a "game-changer" for unlocking stored oil and achieving energy independence, has ignited strong bullish sentiment, anticipating significant price appreciation. However, skeptics caution that the company still faces an "uphill legal battle" from environmental groups, raising concerns about potential pump-and-dump scenarios and ongoing financial hurdles despite the recent regulatory win.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Make a Hack-Proof Portfolio With Cybersecurity ETFs

As AI adoption surges and cyberattacks escalate, cybersecurity ETFs like CIBR and HACK stand out as investors seek digital defense gains.

Commvault Systems Inc. (CVLT) stock reached an all-time high after attracting bullish attention from Wall Street following a standout first quarter (Q1) and an upgraded forecast for the year.&nbsp;The data protection and cybersecurity company received price target boosts from several brokerages, citing strong performance and momentum in the backup and recovery segment.<a href="https://stocktwits.com/symbol/CVLT">Commvault Systems stock</a> pared some of the gain and traded at $193.52 at the time of writing.On Stocktwits, retail sentiment toward the stock remained in ‘bullish’ (73/100) territory. Message volume improved to ‘extremely high’ (79/100) from ‘high’ levels in 24 hours.<figure class="image"><img style="aspect-ratio:959/115;" src="https://news.stocktwits-cdn.com/Screenshot_2025_07_30_102918_png_578e262c7f.webp" alt="CVLT’s Sentiment Meter and Message Volume as of 10:35 a.m. ET on July 30, 2025 | Source: Stocktwits" width="959" height="115"><figcaption>CVLT’s Sentiment Meter and Message Volume as of 10:35 a.m. ET on July 30, 2025 | Source: Stocktwits</figcaption></figure>KeyBanc Capital Markets raised its price target on Commvault to $225 from $195, while maintaining its ‘Overweight’ rating, as per TheFly.&nbsp;The brokerage expressed confidence in the company's accelerating performance trajectory, highlighting better-than-expected annual recurring revenue (ARR) in constant currency terms and a positive full-year outlook.&nbsp;DA Davidson also lifted its price target to $220 from $200 and reiterated a ‘Buy’ rating.&nbsp;The firm noted that a few significant contracts signed just before quarter-end contributed to the strong numbers.&nbsp;DA Davidson expects Commvault's Cyber Resilience offerings, which command higher average selling prices, to make up a growing portion of the company’s future ARR.Cantor Fitzgerald raised its target to $189 from $173, but maintained a ‘Neutral’ stance on the stock.&nbsp;The brokerage acknowledged Commvault’s Q1 beat and revised fiscal 2026 guidance, attributing these results to broader industry tailwinds and the company’s operational discipline.&nbsp;The firm said the improved fundamentals are already being reflected in the stock’s valuation.Commvault’s Q1 ARR climbed 24% year-on-year (YoY) to $996 million, and the subscription grew 46% YoY to $182 million.The company’s revenue of $282 million and adjusted earnings per share (EPS) of $1.01 surpassed the analysts’ consensus estimate of $267 million and $0.97, respectively, as per Fiscal AI data.Commvault stock has gained over 28% in 2025 and in the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/marvell-stock-is-trending-on-wednesday-morning/choX5kVR5CT">Marvell Stock Is Trending On Wednesday Morning: Here’s Why South Korea’s Rebellions And Microsoft Are In The Picture</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Commvault Systems, Inc. logo is seen displayed on a smartphone screen.

This Cybersecurity Stock Hit Record Highs And Drew Wall Street Praise After Blowout Q1: More Details Inside

The data protection and cybersecurity company received price target boosts from several brokerages, citing strong performance and momentum in the backup and recovery segment.

Commvault Stock Hits Record High And Draws Wall Street Praise After Blowout Q1: Retail Joins The Party

Equity

Datadog Inc. (DDOG), a provider of monitoring and security platforms for&nbsp;cloud-scale applications, has received positive evaluations from Wall Street&nbsp;analysts following its annual conference, DASH, held in New York on June 9th and 10th.Wolfe Research upgraded Datadog (DDOG) from ‘Peer Perform’ to ‘Outperform’, setting a new price target of $150, as per TheFly.&nbsp;Following the company's DASH conference, the research firm expressed greater optimism about Datadog’s near-term growth potential, particularly in artificial intelligence. It reaffirmed its belief in the company’s “market-leading products” as a key driver of sustained success.In a note to investors, the brokerage argued that the stock, down 17% so far this year, undervalues Datadog’s strong growth and margin trajectory.&nbsp;Datadog recently raised its outlook, projecting 20% year-over-year (YoY) revenue growth for 2025, which places it among the elite tier of “Heavyweight Growth” peers.&nbsp;Wolfe’s “upside model” anticipates growth in the mid-20% range for 2025, with annual gains exceeding 20% projected through 2027.Needham analyst Jack Andrews increased the firm's price target to $140, up from $130, while maintaining a ‘Buy’ rating on the stock.&nbsp;In a note to investors, Andrews highlighted the wave of new product rollouts unveiled at the company's recent DASH conference, emphasizing the deep integration of AI across the platform as a key takeaway.The analyst noted that Needham remains impressed with the company’s rapid innovation cycle and sees Datadog’s evolving platform as a significant factor in securing large enterprise deals and expanding market share.At its annual conference, Datadog introduced three new AI agents: Bits AI SRE, Dev Agent, and Security Analyst, designed to support development, security, and operations teams with real-time troubleshooting and automated code fixes.&nbsp;The company launched its Internal Developer Portal (IDP) at the DASH conference, marking the first developer portal powered by real-time observability data.On Stocktwits, retail sentiment around Datadog remained in ‘bullish’ territory.<figure class="image"><img style="aspect-ratio:802/94;" src="https://news.stocktwits-cdn.com/Screenshot_2025_06_12_131257_png_1f3f6ecd8f.webp" alt="DDOG's Sentiment Meter and Message Volume as of 01:20 p.m. ET on Jun.12, 2025 | Source: Stocktwits" width="802" height="94"><figcaption>DDOG's Sentiment Meter and Message Volume as of 01:20 p.m. ET on Jun.12, 2025 | Source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/DDOG">Datadog stock</a> has lost over 13% year-to-date and has gained 3% in the last 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/imax-expands-stock-buyback-program-by-100-million/chlgPOTRRGR">IMAX Expands Stock Buyback Program By $100M: Retail Traders Shift To Neutral Ground</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Datadog, Inc. logo appears on the screen of a smartphone in Reno, United States, on December 7, 2024. 

Datadog Wins Over Analysts With Bold AI Push: Retail Echoes Confidence

Datadog earned analyst upgrades after unveiling AI-focused innovations at its DASH conference, with Wolfe and Needham citing strong growth potential and rising enterprise demand.

Why Cybersecurity ETFs Deserve a Spot in Your Portfolio

Datadog, Inc. (DDOG) shares retreated sharply in Thursday’s premarket session after the company issued disappointing guidance despite delivering a fiscal year 2024 fourth-quarter beat.The New York-based cloud applications monitoring and security platform provider reported fourth-quarter adjusted earnings per share (EPS) of $0.49, exceeding the $0.44 year-ago figure and the $0.43 consensus estimate. The bottom-line result also beat the guidance range of $0.42-$0.44.Revenue climbed 25% year over year (YoY) to $738 million versus the $714.53-million consensus and the $709 million to $713 million guidance range. The topline growth decelerated slightly from the 26% growth in the third quarter.CEO Olivier Pomel said, “We are pleased with our strong execution in fiscal year 2024, with 26% year-over-year revenue growth, $871 million in operating cash flow, and $775 million in free cash flow.”He noted that the company delivered hundreds of new features and capabilities to help customers as they migrated to the cloud and adopted new technologies like next-gen artificial intelligence (AI).Delving into user metrics, Datadog said it had 462 customers with annual recurring revenue (ARR) of over $1 million as of Dec. 31, up 17% YoY.&nbsp;The number of customers with an ARR of over $100,000 increased by 13% to 3,610.Both metrics saw accelerated growth relative to the third quarter.Datadog expects adjusted EPS of $0.41-$0.43 for the first quarter, trailing the $0.45 consensus estimate. It guided revenue in the range of $737 million to $741 million, surrounding the $739.9 million consensus estimate.The company expects full-year adjusted EPS of $1.65 to $1.70 and revenue of $3.175 billion to $3.195 billion. The guidance was below the consensus estimates of $1.98 and $3.24 billion, respectively.<figure class="image"><img style="aspect-ratio:632/131;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/ddog_sentiment_682e798965.png" alt="ddog-sentiment.png" width="632" height="131"><figcaption>DDOG sentiment and message volume February 13, premarket as of 9:24 am ET | Source:&nbsp;Stocktwits</figcaption></figure>On Stocktwits, retail sentiment toward Datadog remained ‘extremely bullish’ (89/100), with the buoyant mood accompanied by ‘extremely high’ volume. The stock is among the top ten trending tickers on the platform;A retail watcher blamed the management’s conservative stance for the disappointing guidance.&nbsp;<stembedurl>https://stocktwits.com/MrChaos/message/604099107</stembedurl>Another user called the post-earnings dip as an “overreaction.”<stembedurl>https://stocktwits.com/classhopper/message/604092667</stembedurl>In premarket trading,&nbsp;<a href="https://stocktwits.com/symbol/DDOG">Datadog stock</a> fell 7.52% to $136.96. The stock has gained 3.6% so far this year.For updates and corrections, email newsroom[at]stocktwits[dot]com&nbsp;Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trade-desk-stock-on-track-for-worst-session-ever-after-mixed-2024-q4-results/ch5XMOnRHb">Trade Desk Stock On Track For Worst Session Ever After Mixed Q4 Results, But Retail Smells ‘Epic Buying Opportunity’</a>

2023/11/08: In this photo illustration, a DataDog logo is displayed on a smartphone.

Datadog Stock Retreats Premarket As Subpar Guidance Takes Sheen Off Strong Q4: Retail Keeps The Faith

The company's quarterly revenue growth slowed slightly quarter-over-quarter, but key user metrics increased at a faster clip.

Datadog, Inc. (DDOG) stock rose in early afternoon trading on Wednesday as investors position for the company’s fiscal year 2024 fourth-quarter results due before the market opens on Thursday.Wall Street analysts expect the New York-based cloud applications monitoring and security platform to report fourth-quarter adjusted earnings per share (EPS) of $0.43 and revenue of $714.53 million. This compares to the year ago’s $0.44 and $589.65 million, respectively.The guidance announced in early November modeled adjusted EPS of $0.46 and revenue of $690 million.Ahead of the fourth-quarter print, Macquarie analyst Steve Koenig said he would prefer to be long into Datadog’s quarterly results and would continue to accumulate the stock.The analyst said, “We're sanguine about prospects for a healthy beat and satisfactory guide.” He added that the company's strong third-quarter performance enabled it to enter the fourth quarter with plenty of headroom to post a typical $17 million+ revenue beat.Koenig said he looks forward to commentary about existing customer usage trends even as he expects this primary driver of near-term revenue performance to be consistent with 2024.He noted that year-to-date (YTD) trends showed strength in enterprise and small and mid-size business segments.Koenig expects the company to guide the first quarter revenue above the consensus estimate and the full-year revenue surrounding the consensus estimate. The company could get more constructive with its EPS guidance due to anticipated strong revenue performance and a low bar for operating margin embedded in consensus estimates, he addedMacquarie has an ‘Outperform’ rating and $200 price target for<a href="https://stocktwits.com/symbol/DDOG"> Datadog stock.</a><figure class="image"><img style="aspect-ratio:628/137;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/ddog_sentiment_27063e247e.png" alt="ddog-sentiment.png" width="628" height="137"><figcaption>DDOG sentiment and message volume February 12, &nbsp;as of 11:06 am ET | Source:&nbsp;Stocktwits</figcaption></figure>On Stocktwits, sentiment toward the stock remained ‘neutral’ (48/100) although the message volume remained at ‘high’ levels.A watcher said he is bullish, attributing his outlook toward the stock to solid fundamentals.<stembedurl>https://stocktwits.com/ImJu0st/message/603922243</stembedurl>But another user dismissed the stock as pricey.<stembedurl>https://stocktwits.com/Treehousebird/message/603883948</stembedurl>The forward price-earnings (P/E) multiple is at 70.42, according to Yahoo Finance data.Datadog stock was up 0.89% at $146.71 in early trading. It is up nearly 2% so far this year.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/teradata-stock-slides-premarket-to-head-toward-6-month-low-after-mixed-q4-results-cfo-exit/ch5aVgBRuO">Teradata Stock Slides Premarket To Head Toward 6-Month Low After Mixed Q4 Results, CFO Exit: Retail Sentiment Sours</a>

Datadog Analyst Long On Stock Ahead Of Q4 Print, But Retail’s Divided

Macquarie analyst Steve Koenig said the company's strong third-quarter performance enabled it to enter the fourth quarter with plenty of headroom to post a typical $17 million+ revenue beat.

WCBR
WisdomTree Trust - WisdomTree Cybersecurity Fund

Feed

News

Sentiment

Fundamentals

Info

Latest WCBR News

WCBRWisdomTree Trust - WisdomTree Cybersecurity Fund